Oorsprong van het eerstegraads netwerk van Xing Bo Gu
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 8 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Xing Bo Gu via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| Stanford University | College/University | Graduate Degree | |
| Yale University | College/University | Graduate Degree | |
| University of Illinois | College/University | Graduate Degree | |
| University of Mississippi | College/University | Masters Business Admin | |
| Nanjing University | College/University | Doctorate Degree Doctorate Degree | |
| The University of Western Australia | College/University | Doctorate Degree | |
| Nanyang Technological University | College/University | Graduate Degree | |
| The Hong Kong University of Science & Technology | College/University | Undergraduate Degree | |
Citigroup Global Markets Asia Ltd.
 Citigroup Global Markets Asia Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Asia Ltd. (CGMA) is a securities brokerage firm headquartered Hong Kong. They are a subsidiary of Citigroup Global Markets Hong Kong Holdings Ltd., ultimately owned by Citigroup, Inc. (NYSE: C) in the US. Formerly known as Citi Smith Barney, the firm was reorganized in 2008 when Citigroup combined their brokerage and private banking businesses. CGMA offers stock trading services to various institutional investors. | Investment Banks/Brokers | Corporate Officer/Principal | |
| BANK OF NANJING CO., LTD. | Regional Banks | Director/Board Member | |
| China Pharmaceutical University | College/University | Graduate Degree | |
| AVIT LTD. | Telecommunications Equipment | Director/Board Member | |
Genor Biopharma Co., Ltd.
 Genor Biopharma Co., Ltd. BiotechnologyHealth Technology Genor Biopharma Co., Ltd. engages in the manufacture and development of antibodies and related biological products. Its business scope includes research and development of monoclonal antibodies and biological products; research and development of instruments, equipment and reagents related to monoclonal antibodies and biological products; and wholesale, import and export of instruments, mechanical equipment, pharmaceutical equipment, and pharmaceutical intermediates. The company was founded on December 4, 2007 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member | |
| NANJING SINOLIFE UNITED COMPANY LIMITED | Pharmaceuticals: Other | Director/Board Member | |
| Shanghai Panxin Equity Investment Management Co. Ltd. | Chief Investment Officer | ||
| SUZHOU NANOMICRO TECHNOLOGY CO., LTD. | Miscellaneous Commercial Services | Director/Board Member | |
Suzhou Xiangyuan New Materials Co., Ltd.
 Suzhou Xiangyuan New Materials Co., Ltd. Chemicals: SpecialtyProcess Industries Suzhou Xiangyuan New Materials Co., Ltd. principally engages in the research, development, production, and sale of polyurethane chain extenders. Its key products are fine chemical products and new polyurethane chain extenders. The company was founded by Jian Zhou on July 3, 2001 and is headquartered in Suzhou, China. | Chemicals: Specialty | Director/Board Member | |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
 PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China. | Miscellaneous Commercial Services | Director/Board Member | |
| ZHAOKE OPHTHALMOLOGY LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| GENOR BIOPHARMA HOLDINGS LIMITED | Biotechnology | Director/Board Member |
Statistieken
Internationaal
| China | 11 |
| Verenigde Staten | 5 |
| Hongkong | 4 |
| Australië | 2 |
| Singapore | 2 |
Sectoraal
| Consumer Services | 10 |
| Health Technology | 5 |
| Finance | 3 |
| Commercial Services | 3 |
| Electronic Technology | 2 |
Operationeel
| Director/Board Member | 15 |
| Independent Dir/Board Member | 7 |
| Graduate Degree | 5 |
| Doctorate Degree | 3 |
| Corporate Officer/Principal | 3 |
Sterkste connecties
| Insiders | |
|---|---|
| Yu Chen | 11 |
| Bo Yu | 4 |
| Bin Qing Xiao | 3 |
| Juan Du | 3 |
| Tao Wen | 2 |
| Tao Wang | 2 |
| Yiou Wang | 2 |
| Chong Bo Xu | 2 |
- Beurs
- Insiders
- Xing Bo Gu
- Bedrijfsconnecties
